Welcome to PsychU!

Early Intervention in Bipolar Disorder

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Early Intervention in Bipolar Disorder

During this webinar, Dr. Goldberg and Dr. Tohen will discuss the importance of early intervention in patients diagnosed with bipolar disorder. Together they will share their clinical experience and discuss the implications of early versus delayed intervention and identify and explore potential treatment options in bipolar disorder.

Objectives:

  • Describe the implications of early versus later intervention in bipolar disorder
  • Explore suitable treatment options in bipolar disorder

Featuring

Joseph-Goldberg

Joseph Goldberg, MD

Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai

More
Dr. Goldberg currently serves as the Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and serves on the Board of Directors for the American Society of Clinical Psychopharmacology. Dr. Goldberg has published over 200 peer-reviewed papers on topics related to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology.
Mauricio-Tohen

Mauricio Tohen, MD, DrPH, MBA

Professor & Chairman at the University of New Mexico Health Sciences Center Department of Psychiatry

More
Dr. Tohen is a Distinguished University Professor at the University of New Mexico and the Chairman of the University of New Mexico’s Department of Psychiatry and Behavioral Sciences. With more than 350 publications and 20,000 scientific citations to his name, Dr. Tohen received in 2016 the Mogens Schou Award for Education and Teaching from the International Society for Bipolar Disorders. In 2017, Dr. Tohen was recognized as one of the world’s leading experts on bipolar disorder based on the breadth and depth of his publications. He earned his medical degree from the National University of Mexico and his Doctorate in Public Health (Epidemiology) from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto, where he additionally obtained a DPsych (Diploma) in Psychiatric Research, and a fellowship at McLean Hospital, Harvard Medical School in Psychopharmacology. Dr. Tohen also obtained an MBA degree from the Indiana University Kelly School of Business.
Jason-Carter

Jason Carter, PharmD (OPDC)

Clinical & Scientific Liaison

Speakers Dr. Joseph Goldberg and Dr. Mauricio Tohen are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Jason Carter, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources